BETTER Access Australia is calling on patient and community groups to sign a petition demanding the Federal Government reverse its indefinite deferral of 44 medicines from the PBS.
The Department of Health recently informed pharmaceutical companies that 44 of the 77 medicines set for review in Mar 2025 by the Pharmaceutical Benefits Advisory Committee (PBAC) will face indefinite delays, citing "workload and resourcing issues".
The PBAC's decision left patients uninformed about which treatments will be impacted, potentially including several cancer, chronic, or rare disease medications.
In 2011, a similar move met strong public and parliamentary opposition, securing bipartisan support for timely PBS listings.
Better Access Australia argued it is time to stand up for access to essential medicines once again.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Nov 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Nov 24
